In an exclusive interview, SMA News Today Senior Columnist Maureen Newman spoke with Dr. Adrian Krainer of Cold Spring Harbor…
Maureen Newman
Maureen Newman is a researcher by trade, and brings her knowledge of the lab to BioNews Texas. Currently, she is serving as a PhD student at University of Rochester, and working towards a career of research in biomaterials for drug delivery and regenerative medicine. She is an integral part of Dr. Danielle Benoit’s laboratory, where she is investigating bone-homing therapeutics for osteoporosis treatment.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Maureen Newman
To better understand spinal muscular atrophy (SMA), scientists must conduct studies using more than just cells in a culture…
Spinal muscular atrophy (SMA) is among the many motor neuron diseases that have no cure. One reason for the…
A new approach to treating spinal muscular atrophy (SMA) is in the works in the laboratory of Matthew E.
Encouraging news from Isis Pharmaceuticals, Inc., presented at the 19th International World Muscle Society Congress in Berlin, demonstrated the…
Parents want what is best for their children, and parents of children with spinal muscular atrophy (SMA) are no…